NeuroPace (NPCE) Cash & Current Investments (2020 - 2026)
NeuroPace's (NPCE) quarterly Cash & Current Investments came in at $54.0 million in Q1 2026, down 18.53% year-on-year from $66.3 million in Q1 2025, and down 11.59% quarter-over-quarter from $61.1 million in Q4 2025.
NeuroPace (NPCE) Cash & Current Investments (2020 - 2026) Analysis & Trends
NeuroPace's Cash & Current Investments history runs 7 years deep, the most recent figure standing at $54.0 million for Q1 2026.
- On a quarterly basis, Cash & Current Investments fell 18.53% year-over-year to $54.0 million in Q1 2026; TTM through Mar 2026 was $54.0 million, a 18.53% decrease from a year earlier, with the FY2025 full-year figure at $61.1 million, up 15.74% from the prior year.
- Cash & Current Investments slipped to $54.0 million in Q1 2026 per NPCE's latest filing, from $61.1 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $103.2 million in Q1 2022 and bottomed at $52.8 million in Q4 2024.
- The 5-year median for Cash & Current Investments is $62.1 million (2025), against an average of $67.3 million.
- Across the five-year window, Cash & Current Investments jumped 237.95% in 2022 and sank 34.47% in 2023, its largest moves.
- Year by year, Cash & Current Investments stood at $77.4 million in 2022, then decreased by 14.15% to $66.5 million in 2023, then declined by 20.61% to $52.8 million in 2024, then increased by 15.74% to $61.1 million in 2025, then dropped by 11.59% to $54.0 million in 2026.
- Per Business Quant, the three latest NPCE Cash & Current Investments figures stand at $54.0 million (Q1 2026), $61.1 million (Q4 2025), and $60.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.12 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 577.00 Mn |
| 10 | NeuroPace | 494.96 Mn | 440.98 Mn | 18.05 Mn | 53.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53.98 Mn |
| Dec 31, 2025 | 61.06 Mn |
| Sep 30, 2025 | 60.01 Mn |
| Jun 30, 2025 | 62.14 Mn |
| Mar 31, 2025 | 66.26 Mn |
| Dec 31, 2024 | 52.76 Mn |
| Sep 30, 2024 | 56.83 Mn |
| Jun 30, 2024 | 55.54 Mn |
| Mar 31, 2024 | 58.95 Mn |
| Dec 31, 2023 | 66.45 Mn |
| Sep 30, 2023 | 61.35 Mn |
| Jun 30, 2023 | 63.57 Mn |
| Mar 31, 2023 | 67.62 Mn |
| Dec 31, 2022 | 77.41 Mn |
| Sep 30, 2022 | 85.41 Mn |
| Jun 30, 2022 | 92.41 Mn |
| Mar 31, 2022 | 103.18 Mn |
| Dec 31, 2021 | 115.58 Mn |
| Sep 30, 2021 | 123.33 Mn |
| Jun 30, 2021 | 127.92 Mn |